Volume 85 Issue 44 | p. 16 | Concentrates
Issue Date: October 29, 2007

Ranbaxy To Spin Off Drug Discovery Arm

Department: Business

Ranbaxy Laboratories has taken the first steps to spinning off its drug discovery unit. The Indian company says establishing independence for the R&D unit will provide the flexibility needed to accelerate development of its drug pipeline. Ranbaxy is one of a number of Indian companies previously focused on generic drugs or contract research that have forged into internal drug discovery. This summer, Nicholas Piramal India revealed plans to create a separate R&D unit.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment